Theravance Biopharma (TBPH) to resume trading at 4:35PM ET after a trial did not meet the primary endpoint
Theravance Biopharma (NASDAQ: TBPH) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
